10-K: BranchOut Food Reports Soaring Revenue Amidst Deepening Losses
Annual Report
BranchOut Food Inc. announced a 113% surge in net revenue for 2025, reaching $13.7 million, yet reported a significant increase in net loss to $6.1 million, raising substantial doubt about its ability to continue as a going concern.
Summary
- Net revenue for the fiscal year ended December 31, 2025, increased by 113% to $13.7 million, up from $6.4 million in 2024, driven by higher sales volumes and new product introductions.
- Gross profit rose to $2.05 million in 2025 from $0.8 million in 2024, with gross margin improving to 14.8% from 12.2%.
- Adjusted gross margin (non-GAAP) for 2025 was 27.8%, excluding depreciation, certain air freight costs, and IEEPA tariffs.
- Net loss increased to $6.1 million in 2025, compared to $4.8 million in 2024, primarily due to expanded commercial activities, higher administrative costs, and costs associated with scaling production at the Peru Facility.
- Operating expenses increased to $7.4 million in 2025 from $4.7 million in 2024, reflecting the company's growth and public company costs.
- Cash used in operating activities increased to $7.0 million in 2025 from $4.9 million in 2024, driven by higher operating losses and increased working capital investment.
- The company reported negative working capital of $584,240 as of December 31, 2025, an improvement from negative $3.9 million in 2024.
- Auditors expressed substantial doubt about the company's ability to continue as a going concern due to recurring losses and insufficient cash on hand.
- The Peru manufacturing facility, which commenced operations in December 2024, operated below normalized utilization levels during 2025, leading to $1.2 million in idle capacity expense.
- Three customers accounted for approximately 96.8% of net revenue and 97% of accounts receivable in 2025, indicating high customer concentration.
- A potential tariff refund of $348,752, related to tariffs ruled unlawful, is treated as a gain contingency and not recognized in the 2025 financial statements.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing with significant caution. While revenue growth and gross margin improvement are positive, the increasing net losses, substantial cash burn, and the explicit 'going concern' warning from auditors indicate severe financial distress. The identified material weaknesses in internal controls further compound the risk, suggesting fundamental operational and governance challenges despite efforts to scale.
Positives
- Net revenue increased significantly by 113% to $13.7 million in 2025, demonstrating strong sales growth.
- Gross profit improved by 160% to $2.05 million, and gross margin increased to 14.8% from 12.2% in the prior year, reflecting increased internal manufacturing and logistics efficiencies.
- Adjusted gross margin (non-GAAP) of 27.8% indicates better underlying unit economics as the Peru facility scales.
- Net loss as a percentage of net revenue improved to 44.6% in 2025 from 73.8% in 2024, showing some leverage from revenue growth.
- Working capital improved to negative $584,240 in 2025 from negative $3.9 million in 2024, primarily due to debt repayments and increased current assets.
- The company substantially completed its organizational realignment to in-house production at the Peru Facility by December 31, 2025.
- Repaid $1.2 million Senior Secured Promissory Note from Kaufman Kapital and $1.56 million of Senior Secured Notes from Eagle Vision during 2025.
Negatives
- Incurred a net loss of $6.1 million in 2025, an increase from $4.8 million in 2024, indicating continued unprofitability.
- Auditors expressed substantial doubt about the company's ability to continue as a going concern.
- Cash balance significantly decreased to $616,278 at December 31, 2025, from $2,329,452 at December 31, 2024.
- Operating expenses increased by 58% to $7.4 million, outpacing gross profit growth.
- The Peru Facility operated below normalized utilization, resulting in $1.2 million in idle capacity expense in 2025.
- High customer concentration, with three customers accounting for approximately 96.8% of net revenue in 2025, poses a significant risk.
- Identified material weaknesses in internal control over financial reporting, including lack of formal control for related party transactions, incomplete policies, and insufficient segregation of duties.
- Recorded a $401,522 loan receivable impairment in 2025 for the Nanuva note due to discontinuing third-party manufacturing and bankruptcy uncertainty.
Risks
- History of losses and negative cash flows, with no assurance of achieving or sustaining profitability.
- Substantial doubt about the ability to continue as a going concern, which may hinder capital raising and operations.
- Need for additional capital to fund operations and growth, with no guarantee of availability on acceptable terms.
- Risks associated with operating and manufacturing in Peru, including political, economic, regulatory, currency, labor, and supply chain instability.
- Inability to scale production efficiently, improve manufacturing utilization, and maintain product quality.
- High customer concentration, making the company vulnerable to changes in purchasing patterns or loss of key customers.
- Dependence on licensed GentleDry technology from EnWave Corporation, with risks of limitations, disputes, or loss of exclusivity.
- Challenges in accurately forecasting demand, managing inventory, and executing growth initiatives.
- Volatility in the market price of common stock due to operating results, liquidity constraints, and financing activities.
- Potential dilution to existing stockholders from future equity or debt financings.
- Failure to maintain effective internal control over financial reporting, leading to potential errors, restatements, or delayed reporting.
- Disruptions at the single manufacturing facility in Pisco, Peru, could severely impact production and revenue.
- Exposure to foreign currency fluctuations, particularly between Peruvian Soles and U.S. Dollars, without hedging.
- Vulnerability to agricultural supply conditions, environmental factors, and commodity price volatility.
- Inventory management challenges, product shelf-life limitations, and potential obsolescence affecting margins and cash flows.
- Insufficient insurance coverage for potential losses, including natural disasters, cyber incidents, or product liability claims.
- Impact of tariffs on imported products into the United States, increasing costs and potentially decreasing demand.
- Reliance on a limited number of key suppliers and service providers, exposing the company to supply chain concentration risk.
- Inflation and cost pressures on labor, transportation, raw materials, and utilities could adversely affect margins.
- Litigation and regulatory proceedings, such as the lawsuit by the former CFO, could result in significant costs and reputational harm.
- Disruptions to information technology systems or cybersecurity incidents could harm operations and financial reporting.
- Dependence on a limited number of key personnel, including a Chief Financial Officer who is not a full-time employee.
Future Outlook
The company is in a growth and scaling phase, with near-term operating performance dependent on revenue growth, production scale, cost management, and capital availability. Management expects operating leverage to improve as production scales at the Peru Facility, leading to better reported gross margins. Product development efforts are focused on expanding the snack portfolio and supporting private label programs, including new products with higher protein and fiber content. Capital expenditures were incurred in early 2026 to expand manufacturing capabilities for high-protein dairy applications, which are expected to be more efficient to produce. The company remains dependent on external financing to support operations and working capital requirements for at least the next twelve months.
Management Comments
- Management believes its experience navigating cross-border manufacturing and logistics supports scalable growth within the current global trade environment.
- Management believes that this growth-stage, manufacturing-focused approach allows us to compete effectively by pairing differentiated products with scalable operations, while managing the complexity and execution demands inherent in expanding within the consumer-packaged foods industry.
- Management continues to focus on increasing production volumes, improving manufacturing efficiency, managing working capital, and supporting distribution expansion.
- Management believes these factors will contribute toward achieving profitability (referring to initiatives to increase revenues and seek additional capital).
Industry Context
StockSavvy.ai notes that BranchOut Food operates within the highly competitive U.S. consumer packaged foods (CPG) industry, specifically targeting the growing 'better-for-you' snack segment, estimated at $50.4 billion in 2024. The company's focus on clean-label, plant-based, and minimally processed products aligns with shifting consumer preferences. However, the industry is characterized by intense competition from established brands and expanding private-label assortments, which reached a record $282.8 billion in 2025. BranchOut's manufacturing-led strategy and proprietary GentleDry technology aim to differentiate its offerings, but its smaller scale compared to larger competitors may limit its bargaining power and increase exposure to market volatility.
Comparison to Industry Standards
- BranchOut Food's gross margin of 14.8% (27.8% adjusted non-GAAP) is below typical established CPG companies, which often achieve gross margins in the 30-50% range, reflecting its early-stage manufacturing scale-up and fixed cost absorption challenges. For example, larger snack companies like Mondelez International or PepsiCo's Frito-Lay division typically operate with significantly higher gross margins due to scale and brand power.
- The company's high customer concentration, with three customers accounting for nearly 97% of revenue, is significantly higher than industry averages for diversified CPG companies, which typically have a broader customer base to mitigate risk. This makes BranchOut highly susceptible to changes in purchasing decisions from a few key retailers, unlike more established players with widespread distribution.
- The reliance on a single manufacturing facility in Pisco, Peru, contrasts with the geographically diversified production footprints of major food manufacturers, which often have multiple facilities to ensure supply chain resilience and mitigate regional risks.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | NA | John Dalfonsi | 2024-01-10 | Appointment to the role. |
| Director | NA | Deven Jain | 2024-07-24 | Appointment upon closing of investment by Kaufman Kapital, LLC. |
| Director | NA | Lindsey L. Schwartz | 2025-02-13 | Appointment to the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weakness | No formal control process related to the identification and approval of related party transactions. | 2025-12-31 | Increases risk of unapproved or unfavorable related party dealings and potential financial misstatements. |
| Internal Control Weakness | Lack of a formal and complete set of policies and procedures covering internal controls over financial reporting. | 2025-12-31 | Hinders consistent and reliable financial reporting and increases risk of errors or fraud. |
| Internal Control Weakness | Did not maintain effective internal controls to assure proper segregation of duties. | 2025-12-31 | Increases the risk of errors, fraud, and unauthorized transactions due to insufficient checks and balances. |
| Internal Control Weakness | Lack of resources to evaluate and review appropriate accounting treatment for certain complex areas, such as deferred tax assets, unique transactions, and share-based compensation. | 2025-12-31 | Increases the risk of material misstatements in complex financial reporting areas. |
| Audit Committee Composition | No member of the Audit Committee currently meets the qualifications of an audit committee financial expert. | 2024-01-01 | May reduce the effectiveness of the Audit Committee's oversight of financial reporting and internal controls. |
Legal Proceedings
- The company is a party to a lawsuit filed by its former Chief Financial Officer on June 25, 2025, in the Superior Court of the State of Washington, alleging wrongful termination and seeking damages. The company believes the claims are without merit and is engaged in settlement discussions, with the ultimate outcome and timing remaining uncertain.
Related Party Transactions
- Kaufman Kapital LLC, a beneficial owner (>10% common stock), provided a $3.4 million Senior Secured Convertible Promissory Note (Convertible Note) and warrants in 2024. In 2025, Kaufman Kapital exercised a $1.00 warrant for $1 million cash. Subsequent to year-end, Kaufman Kapital converted $500,000 of the Convertible Note principal into 659,457 shares of common stock and provided a new $1.5 million Senior Secured Promissory Note.
- Kaufman Kapital LLC also provided a $1.2 million Senior Secured Promissory Note on August 29, 2024, which was fully repaid by the company during 2025 through principal payments totaling $1.2 million.
- Eagle Vision Fund LP, an affiliate of CFO John Dalfonsi, participated in financing transactions in 2024, providing $1,675,000 in Senior Secured Notes and warrants. The company repaid $1,560,000 of these notes during 2025, fully settling them. Warrants held by purchasers of these notes were exercised for 350,000 shares, generating $350,000 in cash proceeds.
- Eric Healy (CEO) and the company's President purchased $525,000 of Units (common stock and warrants) on July 15, 2024.
Stakeholder Impact
- Shareholders face significant dilution risk from ongoing capital raises (ATM offerings, warrant exercises, convertible debt conversions) to fund operations and growth.
- Shareholders are exposed to substantial financial risk due to recurring losses, negative cash flows, and the 'going concern' warning, which could lead to further stock price volatility and potential loss of investment.
- Employees in Peru (approximately 98% of the workforce) are critical to manufacturing and supply chain, and their stability and working conditions are emphasized, contributing to product quality and reliability.
- Customers may benefit from expanded product offerings and improved manufacturing efficiency at the Peru facility, but customer concentration poses a risk if key relationships are disrupted.
- Creditors, particularly Kaufman Kapital LLC, have significant secured positions on company assets, indicating a high level of leverage and potential risk in case of financial distress.
- Suppliers face risks related to the company's financial stability and reliance on a limited number of key vendors, which could impact payment terms or ongoing relationships.
Next Steps
- Increase production volumes and improve manufacturing efficiency at the Peru Facility.
- Expand distribution of existing retail customers and develop new customer relationships.
- Introduce new products, including those with higher protein and fiber content, tailored to evolving consumer preferences.
- Manage working capital and maintain access to capital to fund operations and growth initiatives.
- Address identified material weaknesses in internal control over financial reporting, particularly regarding related party transactions, policies and procedures, segregation of duties, and complex accounting treatments.
- Continue settlement discussions regarding the lawsuit filed by the former Chief Financial Officer.
Key Dates
| Date | Description |
|---|---|
| 2017-02-21 | Company originally incorporated as AvoChips Inc., an Oregon corporation. |
| 2017-11-02 | AvoChips Inc. converted into Avochips, LLC, an Oregon limited liability company. |
| 2020-05-17 | Company entered into an EIDL Loan Agreement with the SBA. |
| 2021-02-04 | Company entered into a Manufacturing and Distributorship Agreement (MDA) with Natural Nutrition SpA (Nanuva). |
| 2021-05-07 | Company entered into a license agreement with EnWave Corporation for GentleDry technology. |
| 2021-11-19 | Avochips, LLC converted into a Nevada corporation named BranchOut Food Inc. |
| 2022-01-01 | Effective date of the 2022 Equity Incentive Plan. |
| 2022-01-19 | Company entered into a contract manufacturing agreement with NXTDried Superfoods SAC. |
| 2022-04-12 | Consulting agreement with John Dalfonsi (CFO) dated. |
| 2022-12-06 | Employment agreement with Eric Healy (CEO) dated. |
| 2023-05-09 | Finance lease for production equipment commenced. |
| 2023-05-22 | Company entered into an equipment purchase agreement with EnWave for the Third EnWave Machine. |
| 2023-06-15 | Company effected a 2.5-for-1 reverse stock split. |
| 2023-06-16 | Shares of common stock began trading on the Nasdaq Capital Markets under the symbol BOF. |
| 2024-01-09 | Company entered into a Subscription Agreement with Eagle Vision Fund LP for Senior Secured Notes and Warrants. |
| 2024-01-10 | John Dalfonsi appointed Chief Financial Officer and consulting agreement amended. |
| 2024-04-01 | Organizational realignment initiated to expand manufacturing capabilities through the Peru Facility. |
| 2024-04-16 | Company amended the Subscription Agreement with Eagle Vision Fund LP (First Amendment). |
| 2024-05-10 | Company entered into a ten-year lease for the 50,000 square-foot manufacturing facility in Pisco, Peru. |
| 2024-05-10 | Company made the first payment of $275,000 toward the first mortgage position on the Peru Facility. |
| 2024-05-14 | Company completed the sale of $1,050,000 of Senior Secured Notes and Warrants to a group of investors led by Eagle Vision. |
| 2024-07-15 | Company entered into a Securities Purchase Agreement (SPA) with Daniel L. Kaufman for a Convertible Note and Warrants. |
| 2024-07-15 | Company entered into Subscription Agreements with Eric Healy, Eagle Vision, and the Company's President for Unit Offering. |
| 2024-07-19 | Company, Mr. Kaufman, and Kaufman Kapital LLC amended the SPA, replacing Mr. Kaufman with Kaufman Kapital as the Investor. |
| 2024-07-23 | Company entered into an Omnibus Amendment to Note Documents with holders of Senior Secured Notes. |
| 2024-07-24 | Initial loan payment of $2,000,000 was made to the Company under the Convertible Note from Kaufman Kapital. |
| 2024-07-24 | Deven Jain appointed to the Board of Directors. |
| 2024-07-30 | Company repaid an aggregate total of $115,000 of principal to Purchasers in settlement of their Senior Secured Notes. |
| 2024-08-29 | Company borrowed $1,200,000 from Kaufman Kapital pursuant to a Senior Secured Promissory Note. |
| 2024-12-09 | Kaufman Kapital made an additional loan to the Company under the Convertible Note in the amount of $1,400,000. |
| 2024-12-31 | Peru Facility commenced operations. |
| 2025-02-13 | Lindsey L. Schwartz appointed to the Board of Directors. |
| 2025-04-15 | Annual base salary of Eric Healy increased from $250,000 to $325,000. |
| 2025-05-07 | Company repaid $325,000 of principal on the Secured Note to Kaufman Kapital. |
| 2025-06-01 | Company and Kaufman Kapital entered into a Warrant Exercise and Amendment to Notes and Warrant Agreement. |
| 2025-06-04 | Kaufman Kapital exercised in full the $1.00 Warrant for a cash payment of $1,000,000. |
| 2025-06-25 | Lawsuit filed by former Chief Financial Officer alleging wrongful termination. |
| 2025-09-16 | Company entered into a Purchase Agreement for the Third EnWave Machine for $1,500,000. |
| 2025-09-30 | Company repaid $375,000 of principal on the Secured Note to Kaufman Kapital. |
| 2025-11-13 | Company completed the sale of 1,034,600 shares of common stock in an underwritten offering. |
| 2025-11-14 | Company issued warrants to purchase 41,384 shares of common stock in connection with an underwritten offering. |
| 2025-11-17 | Company repaid $500,000 of principal on the Secured Note to Kaufman Kapital. |
| 2025-12-31 | Fiscal year end. Organizational realignment substantially completed. |
| 2026-01-27 | Company entered into an At-The-Market Issuance Sales Agreement (ATM Agreement) with Alexander Capital, L.P. |
| 2026-01-28 | Company borrowed $1,500,000 from Kaufman Kapital LLC via a Senior Secured Promissory Note. |
| 2026-01-28 | Kaufman Kapital converted $500,000 of principal outstanding under the Convertible Note into 659,457 shares of common stock. |
| 2026-02-10 | Compensation Committee approved the grant of 1,390,000 stock options under the 2022 Plan. |
| 2026-02-13 | As of this date, the Company had issued and sold 500,000 shares of common stock under the ATM Agreement for aggregate gross proceeds of $1,499,873. |
| 2026-02-24 | Warrants were exercised to purchase 37,500 shares of common stock for $37,500 cash proceeds. |
| 2026-03-04 | U.S. Court of International Trade ruled certain tariffs imposed under the IEEPA unlawful, potentially entitling the Company to a $348,752 refund. |
| 2026-03-31 | Date of filing of the Annual Report on Form 10-K. |
Recommendation
strong sellDespite strong revenue growth and an improved gross margin, the company's financial position is precarious, marked by increasing net losses, a rapidly dwindling cash balance, and an explicit 'going concern' warning from its auditors. The identified material weaknesses in internal controls suggest fundamental governance and operational deficiencies. While recent capital raises provide temporary liquidity, they also indicate ongoing financial strain and significant dilution for existing shareholders. The high customer concentration and reliance on a single manufacturing facility in Peru further amplify operational risks. For a seasoned investor, these severe red flags, particularly the going concern and internal control issues, outweigh the growth narrative, making the stock a 'strong sell' due to the high probability of further value erosion and potential insolvency.
Keywords
Plant-based snacks, Dried fruit, Dehydrated vegetables, Consumer packaged goods, CPG, GentleDry technology, EnWave Corporation, Peru manufacturing, SEC filing, 10-K, Financial results, Going concern, Nasdaq, Food industry, Private label, Industrial ingredients, Supply chain, Capital raise, Internal controls
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.